
Sagimet Biosciences
formerly Sagimet Biosciences Inc. Series AIPOSagimet Biosciences is a biotech company in San Mateo, United States, founded in 2006. It has raised $153.5M across 4 rounds, most recently an $80.0M Growth Equity in February 2021.
Advancing FASN Inhibitors for Metabolic Disease
- Headquarters
- San Mateo, California
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Website
- sagimet.com
- Total Funding
- $153.5M
- Last Round
- $80.0M Growth EquityFeb 2021
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.
About
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways caused by overproduction of the fatty acid palmitate. FASN regulates lipid synthesis and is implicated in acne, metabolic dysfunction-associated steatohepatitis (MASH), and certain FASN-dependent tumors. Lead candidate denifanstat is an oral FASN inhibitor with a Phase 3-ready MASH program and additional dermatology and oncology development, including the topical FASN inhibitor TVB-3567.
Summary
It lists 11–50 employees. It has raised $153.5M in total across 4 rounds, most recently a $80.0M Growth Equity round in Feb 2021. Investors include Ascletis, Kleiner Perkins and New Enterprise Associates.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jul 2023
Sign up to see all 5 events
Funding: Series C through Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sagimet-biosciences"><img src="https://indexed.vc/api/badge/company/sagimet-biosciences" alt="Sagimet Biosciences on Indexed.vc" width="260" height="76" /></a>

